The UAE’s progress in addressing Alzheimer’s disease has been spotlighted in a new report by The Economist Impact, commissioned by global pharmaceutical leader Eli Lilly.
Launched at the 5th Abu Dhabi Brain Conference, the report highlights the country’s proactive measures and outlines strategies to reinforce its role as a global healthcare leader.
With more than 55 million people worldwide living with dementia, the UAE has been recognized for initiatives such as awareness campaigns led by the Ministry of Health and Prevention and the 4-get-me-not charity, alongside Sharjah’s designation by the World Health Organization as the region’s first Arab Age Friendly City. These steps have positioned the nation as a model in healthy aging and community support.
The report, titled Changing the Narrative: Alzheimer’s Disease in the UAE, recommends further action in three areas. A national policy dedicated to Alzheimer’s disease would create a coordinated, evidence-based framework involving government, academia, industry, patients, and caregivers. Expanding training for healthcare professionals, particularly primary care providers, would enable earlier diagnosis and intervention. Greater investment in public education would also help reduce stigma and encourage timely support-seeking.
“Breakthroughs in science are transforming how we detect and treat Alzheimer’s disease,”
said Roberta Marinelli, President and General Manager for Eli Lilly Middle East and Türkiye.
“Progress happens faster when we act together, and by partnering with the UAE’s healthcare community, we aim to set benchmarks that can shape global practice.”
By combining innovation, policy development, and community engagement, the UAE is advancing a comprehensive response to Alzheimer’s disease, strengthening its position as a hub for healthcare leadership and research.
News Source: Emirates News Agency
